New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed that ...
Eli Lilly’s crop of new products propelled the company to 8% sales growth in the fourth quarter, but the most pleasing aspect for the firm was likely the resilience of its diabetes blockbuster ...
A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be less likely to develop epilepsy than those taking DPP-4 inhibitors.
The Therapeutic Goods Administration said the warnings, across the GLP-1 RA class of medicines, had been aligned to ensure consistent information “regarding the potential risk of suicidal thoughts or ...
WASHINGTON – For 14 years, Jesse’s mind spiraled. So did his weight. The medications he took for schizophrenia drove his weight up until he nearly hit the 300-pound mark. His mom wanted to get him on ...
MSK Breast Medical Oncologist Sherry Shen, MD, is an expert in the relationship between obesity, diet, and cancer. Her research includes studying new weight loss drugs such as Zepbound, Wegovy, and ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback